As of 2024-12-11, the Fair Value of Karo Pharma AB (KARO.ST) is -17.36 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 60.30 SEK, the upside of Karo Pharma AB is -128.79%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | 14.52 | 657.38 | 8.89 | 82.05 | -17.45 | 149.08 |
| YoY growth | -84.81% | 4,428.63% | -98.65% | 822.94% | -121.27% | 989.37% |
| Market Cap (mil) | 16,477.28 |
| P/E | |
| Forward P/E | 257.16x |
| EPS | -0.69 |
| Avg earnings growth rate | 989.37% |
| TTM earnings | -189.75 |